Medpace

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medpace and other ETFs, options, and stocks.

About MEDP

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.

CEO

August James Troendle

CEOAugust James Troendle

Employees

6,200

Employees6,200

Headquarters

Cincinnati, Ohio

HeadquartersCincinnati, Ohio

Founded

1992

Founded1992

Employees

6,200

Employees6,200

MEDP Key Statistics

Market cap

16.67B

Market cap16.67B

Price-Earnings ratio

33.93

Price-Earnings ratio33.93

Dividend yield

—

Dividend yield—

Average volume

199.88K

Average volume199.88K

High today

$597.47

High today$597.47

Low today

$571.01

Low today$571.01

Open price

$578.29

Open price$578.29

Volume

157.81K

Volume157.81K

52 Week high

$677.90

52 Week high$677.90

52 Week low

$373.00

52 Week low$373.00

Stock Snapshot

With a market cap of 16.67B, Medpace(MEDP) trades at $597.12. The stock has a price-to-earnings ratio of 33.93.

As of 2026-08-18, Medpace(MEDP) stock has fluctuated between $571.01 and $597.47. The current price stands at $597.12, placing the stock +4.6% above today's low and -0.1% off the high.

Medpace(MEDP) shares are trading with a volume of 157.81K, against a daily average of 199.88K.

During the past year, Medpace(MEDP) stock moved between $373.00 at its lowest and $677.90 at its peak.

MEDP News

TipRanks 3d

Medpace CEO Makes Bold Multi-Million Move With Fresh Stock Sale

New insider activity at Medpace Holdings ( (MEDP) ) has taken place on August 14, 2026. Unlock powerful investing tools with TipRanks Premium to make smarter,...

Benzinga 3d

If You Invested $100 In Medpace Holdings Stock 5 Years Ago, You Would Have This Much Today - Benzinga

...

Simply Wall St 4d

Medpace Stock May Sit Below Fair Value While Earnings Look Rich

Medpace Holdings has delivered a strong share price run over the past few years, yet today the valuation picture is split. The Discounted Cash Flow (DCF) intrin...

Analyst ratings

73%

of 15 ratings

Buy

13.3%

Hold

73.3%

Sell

13.3%

More MEDP News

Nasdaq 5d

National Vision Stock Down Despite Q2 Earnings & Revenue Beat

National Vision Holdings, Inc. EYE posted second-quarter 2026 adjusted earnings of 25 cents per share, up 38.9% year over year. The bottom line beat the Zacks C...

Nasdaq 6d

TNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock Up

Tandem Diabetes Care, Inc. TNDM reported a second-quarter 2026 loss of 31 cents per share, narrower than the Zacks Consensus Estimate of a loss of 34 cents. The...

People also own

Based on the portfolios of people who own MEDP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.